查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561552

2024-2032 年按产品类型、应用、配销通路和地区分類的鸦片类药物市场报告

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球鸦片类药物IMARC Group规模达219亿美元。慢性疼痛发生率的上升、老年人口的增加、癌症诊断的增加、医疗保健服务的改善、持续的研发（R＆D）努力、消费者意识的提高以及有利的政府法规是推动市场的一些主要因素。

阿片类药物市场分析：

  • 主要市场驱动因素：阿片类药物市场分析确定了重要因素，例如慢性疼痛、老年人口增长以及关节炎和癌症等疾病盛行率的增加。
  • 主要市场趋势：根据鸦片类药物市场预测，主要趋势包括持续转向开发鸦片类药物的防滥用製剂（ADF），以最大限度地降低成瘾风险。
  • 地理趋势：由于处方率高、医疗保健系统完善以及人口中慢性疼痛的盛行率，阿片类药物市场以北美为主。由于医疗保健支出增加、对疼痛管理方案的认识以及基础设施扩建，其他地区也正在经历成长。
  • 竞争格局：阿片类药物产业的一些主要市场参与者包括勃林格殷格翰国际有限公司、Hikma Pharmaceuticals PLC、Mallinckrodt plc、辉瑞公司、Purdue Pharma LP、赛诺菲SA、Sun Pharmaceutical Industries Ltd. 和Teva Pharmaceutical Industries Ltd.。
  • 挑战与机会：鸦片类药物市场面临挑战，例如更严格的监管控制和对非鸦片类疼痛管理方案的需求增加。然而，有机会开发和销售有效且不太可能导致滥用和成瘾的新鸦片类製剂。

阿片类药物市场趋势：

慢性疼痛的盛行率不断增加

全球慢性疼痛发生率不断上升是阿片类药物产业成长的主要驱动力。 2021 年，超过 20.9% 的美国成年人（5,160 万人）患有慢性疼痛，而 6.9%（1,710 万人）报告患有高影响慢性疼痛（即严重限制日常活动的疼痛）。数百万人患有慢性疼痛，这通常是由关节炎、背部困难或神经性疾病等疾病引起的，这促进了有效疼痛管理治疗的使用。根据美国疾病管制与预防中心 (CDC) 的数据，2019 年至 2021 年，约 5,320 万美国人 (21.2%) 被医生诊断出患有关节炎。因此，阿片类药物因其治疗剧烈疼痛的功效而被医疗保健从业者开出处方。

老年人口不断增加

阿片类药物行业是由不断增长的老年人口推动的。 2022年，65岁以上人口为7.71亿，约占全球人口的10%。 2022年，印度60岁以上人口为1.49亿，约占总人口的10.5%。此外，预计2023年欧盟（EU）人口将达到4.488亿，其中超过五分之一（21.3%）年龄在65岁及以上。老年人更有可能因与年龄相关的疾病（例如退化性关节病和癌症）而忍受慢性疼痛。这增加了对疼痛治疗选择的需求。据估计，在美国 65 岁及以上的成年人中，47% 被诊断出患有关节炎。此外，骨关节炎是第二常见的风湿病，也是最常见的关节疾病，在印度盛行率为 22% 至 39%。近 45% 的 65 岁以上女性有症状，而 70% 的 65 岁以上女性中有放射学证据。

全球癌症发生率上升

癌症诊断率的不断上升，特别是在新兴国家，正在刺激对鸦片类药物的需求。国际癌症研究机构 (IARC) 估计，2022 年将出现 2,000 万新癌症病例和 970 万人死亡。此外，大约五分之一的人在一生中罹患癌症，每九分之一的男性和每十二分之一的女性死于这种疾病。癌症患者经常经历严重的疼痛，鸦片类药物是癌症疼痛治疗的关键组成部分。随着国际上癌症发生率的增加，对有效疼痛管理的需求也在增加，推动了阿片类药物产业的扩张。

阿片类药物市场细分：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品类型、应用和配销通路对市场进行了分类。

按产品类型划分：

  • 可待因
  • 芬太尼
  • 美沙酮
  • 羟考酮
  • 吗啡
  • 氢可酮

羟考酮占大部分市场份额

该报告根据产品类型对市场进行了详细的细分和分析。这包括可待因、芬太尼、美沙酮、羟考酮、吗啡和氢可酮。根据该报告，羟考酮代表了最大的部分。

根据阿片类药物市场统计数据，羟考酮因其强大的止痛特性而成为主导产品类型，这使得它在治疗严重疼痛（包括术后疼痛和癌症相关疼痛）方面非常有效。当其他疼痛治疗方法证明不足时，医生经常会开出羟考酮。此外，製药业在羟考酮缓释製剂的开发上投入了大量资金，以更少的给药间隔提供长期的疼痛缓解。此外，羟考酮的多功能性允许多种给药途径，包括口服片剂、胶囊和静脉製剂，满足不同患者的需求，这反过来又推动了其采用。

按应用划分：

  • 疼痛管理
  • 咳嗽治疗
  • 腹泻治疗
  • 其他的

疼痛管理占产业最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括疼痛管理、咳嗽治疗、腹泻治疗等。报告称，疼痛管理占最大的市场份额。

根据阿片类药物市场趋势，疼痛管理占据最大的市场份额。阿片类药物在医疗保健领域的基本作用以及人们对有效解决疼痛重要性的日益认识正在推动其在疼痛管理应用中的采用。疼痛是一种普遍而复杂的医疗问题，影响着全世界数百万人，阿片类药物被认为是治疗中度至重度疼痛的关键组成部分，特别是在急性和慢性疼痛、术后恢復和癌症相关疼痛中。由于老年人口的迅速增长和癌症诊断发生率的上升，与疼痛相关的疾病普遍存在，从而产生了对有效止痛方法的持续需求，从而扩大了阿片类药物的市场份额。

按配销通路划分：

  • 医院药房
  • 零售药局
  • 药局
  • 网上商店
  • 其他的

该报告根据配销通路对市场进行了详细的细分和分析。这包括医院药局、零售药局、药局、网路商店等。

根据阿片类药物市场概况，医院药房是一个重要的配销通路，因为这些场所是患者第一次接触阿片类药物处方，尤其是在手术后或用于急性疼痛管理时。它们确保受控的分配和使用，在医疗监督下提供阿片类药物的处方和管理之间的直接联繫。

根据鸦片类药物市场分析，零售药局是患者最容易取得鸦片类药物处方以治疗慢性疼痛的地方。它们满足医院外患者的持续需求，促进医疗保健提供者提供护理的连续性。零售药局提供广泛的可用性和便利性，并在某些地区提供咨询服务以确保安全使用，从而增加了阿片类药物市场的收入。

根据阿片类药物市场报告，药局提供更广泛的购物体验，特别注重健康。它们为患者提供了获取药物和其他医疗保健产品的便利选择。药局在阿片类药物行业中的作用强调了获得必要药物与限制获得处方药以防止滥用的责任之间的平衡。

线上药局代表了阿片类药物市场中不断增长的部分，为患者提供便利性并降低药物价格。此外，数位健康技术的快速进步和消费者行为的变化有利于向线上购物的转变。除此之外，线上药局增加了服务不足或农村地区获得疼痛管理解决方案的机会。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美市场领先，占据最大的鸦片类药物市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是阿片类药物最大的区域市场。

根据阿片类药物市场前景，由于多种因素，北美地区占据了市场份额，包括背痛和骨关节炎等慢性疼痛疾病的高患病率、人口老龄化以及阿片类药物在疼痛管理中的广泛使用。除此之外，医疗基础设施的改善和对疼痛管理选择的认识提高导致阿片类药物处方率上升，对阿片类药物市场需求产生了积极影响。此外，专门的成瘾治疗中心和药房已成为分销管道，满足了对这些药物的需求。此外，在更严格的指南和处方监控计划的影响下，不断发展的法规和处方实践正在影响阿片类药物市场的成长。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

  • 根据最近分析阿片类药物市场近期发展的研究发现，领先的製药公司正在大力投资研发（R＆D）以开发创新的鸦片类药物製剂。这些努力的重点是创造具有改进的安全性、减少滥用可能性并增强疼痛管理功效的鸦片类药物。目标是为医疗保健专业人员提供更有效、更安全的治疗选择。此外，阿片类药物市场公司正在密切监控和遵守与阿片类药物处方、分销和使用相关的不断变化的法规和指南。他们正在努力确保其产品符合最高的安全和品质标准，同时遵守严格的监管要求。所有这些努力正在塑造阿片类药物市场的近期价格和机会。

阿片类药物市场新闻：

  • 2021年6月，美国食品药物管理局（FDA）受理普渡製药公司提交的盐酸纳美芬注射新药申请（NDA）并授予优先审查资格。该注射剂是一种阿片拮抗剂，旨在逆转阿片类药物过量。
  • 2024 年 2 月，Hikma Pharmaceuticals PLC 及其全资子公司 Hikma Pharmaceuticals USA Inc. 宣布已原则上达成协议，以解决美国各州、其分支机构和部落国家对该公司提起的几起阿片类药物相关案件。这些案件涉及处方阿片类药物的製造和销售。 Hikma 同意支付最多 1.15 亿美元的现金和 3500 万美元的 Hikma 纳洛酮捐赠，纳洛酮是一种阿片类拮抗剂，用于逆转阿片类药物过量的影响。

本报告回答的关键问题：

  • 迄今为止，全球阿片类药物市场表现如何，未来几年将如何表现？
  • 全球阿片类药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球鸦片类药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的鸦片类药物市场？
  • 依产品类型分類的市场是怎么样的？
  • 阿片类药物市场中最具吸引力的产品类型是什么？
  • 基于应用的市场区隔是什么？
  • 阿片类药物市场中最具吸引力的应用是什么？
  • 基于配销通路的市场区隔是什么？
  • 阿片类药物市场中最具吸引力的配销通路是什么？
  • 市场竞争结构如何？
  • 全球阿片类药物市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球阿片类药物市场表现如何，未来几年将如何表现？
  • 全球阿片类药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球鸦片类药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的鸦片类药物市场？
  • 依产品类型分類的市场是怎么样的？
  • 阿片类药物市场上最具吸引力的产品类型是什么？
  • 基于应用的市场区隔是什么？
  • 阿片类药物市场中最具吸引力的应用是什么？
  • 基于配销通路的市场区隔是什么？
  • 阿片类药物市场中最具吸引力的配销通路是什么？
  • 市场竞争结构如何？
  • 全球阿片类药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球鸦片类药物市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 可待因
    • 市场趋势
    • 市场预测
  • 芬太尼
    • 市场趋势
    • 市场预测
  • 美沙酮
    • 市场趋势
    • 市场预测
  • 羟考酮
    • 市场趋势
    • 市场预测
  • 吗啡
    • 市场趋势
    • 市场预测
  • 氢可酮
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 疼痛管理
    • 市场趋势
    • 市场预测
  • 咳嗽治疗
    • 市场趋势
    • 市场预测
  • 腹泻治疗
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药局
    • 市场趋势
    • 市场预测
  • 药局
    • 市场趋势
    • 市场预测
  • 网上商店
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma LP
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A4559

The global opioids market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032. The rising incidence of chronic pain conditions, increasing elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids Market Analysis:

  • Major Market Drivers: The opioid market analysis identifies important factors, such as chronic pain, growing elderly population, and increasing prevalence of diseases including arthritis and cancer.
  • Key Market Trends: Based on the opioid market forecast, the major trends include the ongoing shift towards the development of abuse-deterrent formulations (ADF) of opioids to minimize the risk of addiction.
  • Geographical Trends: The opioid market is dominated by North America due to high prescription rates, a well-established healthcare system, and the prevalence of chronic pain conditions among its population. Other regions are also experiencing growth due to increased healthcare expenditure, awareness of pain management options, and infrastructure expansion.
  • Competitive Landscape: Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd., among many others.
  • Challenges and Opportunities: The opioid market faces challenges, such as stricter regulatory controls and increased demand for non-opioid pain management options. However, there is an opportunity to develop and market new opioid formulations that are effective and less likely to lead to abuse and addiction.

Opioids Market Trends:

Increasing prevalence of chronic pain

The increasing incidence of chronic pain throughout the world is a primary driver of opioid industry growth. In 2021, over 20.9% of U.S. adults (51.6 million) suffered chronic pain, while 6.9% (17.1 million) reported high-impact chronic pain (i.e., pain that significantly limits daily activities). Millions of people suffer from chronic pain, which is commonly caused by ailments, such as arthritis, back difficulties, or neuropathic disorders, boosting the use of effective pain management treatments. In 2019-2021, around 53.2 million US individuals (21.2%) had arthritis diagnosed by a doctor, according to the Center for Disease Control and Prevention (CDC). As a result, opioids are prescribed by healthcare practitioners because of their effectiveness in treating severe pain.

Growing geriatric population

The opioids industry is driven by the growing geriatric population. In 2022, there were 771 million persons aged 65 and over, accounting for about 10% of the global population. In 2022, 14.9 crore people in India were recorded to be 60 years or older, accounting for approximately 10.5% of the total population. In addition, the population of the European Union (EU) was predicted to be 448.8 million in 2023, with more than one-fifth (21.3%) of it aged 65 and more. Geriatric individuals are more likely to endure chronic pain due to age-related disorders, such as degenerative joint disease and cancer. This has raised the need for pain treatment choices. It is estimated that among adults aged 65 and older, 47% are diagnosed with arthritis in the USA. Also, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Nearly, 45% of women over the age of 65 years have symptoms while radiological evidence is found in 70% of those over 65 years.

Rising cancer rates across the globe

The increasing rate of cancer diagnoses, particularly in emerging nations, is fueling the demand for opioids. The International Agency for Research on Cancer (IARC) estimated that 20 million new cancer cases and 9.7 million deaths occurred in 2022. The expected number of persons who survived 5 years after a cancer diagnosis was 53.5 million. Furthermore, around one in every five persons develops cancer during their lifetime, with one in every nine men and one in every twelve women dying from the condition. Cancer patients frequently experience significant pain, and opioids are a key component of cancer pain therapy. As cancer rates increase internationally, so does the demand for effective pain management, driving the opioid industry expansion.

Opioids Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application, and distribution channel.

Breakup by Product Type:

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Oxycodone accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. According to the report, oxycodone represented the largest segment.

According to the opioids market statistics, oxycodone has emerged as a dominant product type owing to its potent pain-relieving properties, which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is propelling its adoption.

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Pain management holds the largest share of the industry

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes pain management, cough treatment, diarrhea treatment, and others. According to the report, pain management accounted for the largest market share.

Based on the opioid market trends, pain management accounted for the largest market share. Opioid's fundamental role in the healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain refers to a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the burgeoning geriatric population and the rising incidence of cancer diagnoses, thereby creating a sustained demand for effective pain relief methods, is bolstering the opioids market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, drug stores, online stores, and others.

According to the opioids market overview, hospital pharmacies represent a critical distribution channel as these settings are the first encounters of opioid prescriptions for patients, especially after surgeries or for acute pain management. They ensure controlled distribution and use, providing a direct link between the prescription and administration of opioids under medical supervision.

As per the opioids market analysis, retail pharmacies serve as the most accessible point for patients to fill opioid prescriptions for chronic pain management. They cater to the ongoing needs of patients outside the hospital setting, facilitating the continuity of care prescribed by healthcare providers. Retail pharmacies offer widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.

According to the opioids market report, drug stores offer a broader shopping experience with a particular focus on health. They provide a convenient option for patients to access their medications along with other healthcare products. The role of drug stores in the opioid industry underscores the balance between accessibility to necessary medications and the responsibility to limit access to prescription drugs to prevent abuse.

Online pharmacies represent a growing segment in the opioid market, offering patients convenience and lower prices for their medications. Moreover, rapid advancements in digital health technologies and changing consumer behaviors are favoring the shift toward online shopping. Along with this, online pharmacies increase access to pain management solutions in underserved or rural areas.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest opioids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for opioids.

As per the opioids market outlook, The North American region dominated the market share due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the opioid market demand. Moreover, specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs, are influencing the opioid market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • According to recent research that analyzes the opioid market's recent developments, it has been found that leading pharmaceutical companies are investing heavily in research and development (R&D) to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid market companies are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the opioids market's recent price and opportunities.

Opioids Market News:

  • In June 2021, the U.S. Food and Drug Administration (FDA) accepted and granted priority review designation to new drug application (NDA) submitted by Purdue Pharma L.P. for nalmefene hydrochloride injection. The injectable is an opioid antagonist that is designed to reverse opioid overdose.
  • In February 2024, Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., announced that it has reached an agreement in principle to resolve the several opioid related cases brought against the company by U.S. states, their subdivisions, and tribal nations. These cases relate to the manufacture and sales of prescription opioid medications. Hikma agreed to pay up to $115 million in cash and $35 million in donations of Hikma's naloxone, an opioid antagonist that is used to reverse the effects of opioid overdose.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players